0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Penile Pyoderma Gangrenosum Treated With Topical Tacrolimus

Aoife Lally, MRCPI; Kevin Hollowood, FRCPath; Christopher B. Bunker, MD, FRCP; Richard Turner, FRCP
Arch Dermatol. 2005;141(9):1175-1176. doi:10.1001/archderm.141.9.1175.
Text Size: A A A
Published online

Extract

Soto  LD Diaminodiphenylsulfone and steroids in the treatment of pyoderma gangrenosum Int J Dermatol 1970;9293- 300
PubMed Link to Article[[XSLOpenURL/10.1111/ijd.1970.9.issue-4]]
Gungor  EKarakayah  GAlli  N  et al.  Penile pyoderma gangrenosum J Eur Acad Dermatol Venereol 1999;1259- 62
PubMed Link to Article[[XSLOpenURL/10.1111/jdv.1999.12.issue-1]]
Bunker  CB Male Genital Dermatology.  London, England WB Saunders2004;
Porter  WMBunker  CB The dysfunctional foreskin Int J STD AIDS 2001;12216- 220
PubMed Link to Article[[XSLOpenURL/10.1258/0956462011922922]]
Schuppe  H-CHomey  BAssmann  T  et al.  Topical tacrolimus for pyoderma gangrenosum [letter] Lancet 1998;351832
PubMed Link to Article[[XSLOpenURL/10.1016/S0140-6736(05)78962-5]]
Figures in this Article

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Place holder to copy figure label and caption
Figure 1.

Ill-defined granuloma formation seen centrally.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

A, Extensive purulent destruction of glans (picture taken just prior to commencement of topical 0.1% tacrolimus); B, resolution of inflammation observed 2 weeks after commencement of topical 0.1% tacrolimus.

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 8

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs
brightcove.createExperiences();